L. Morgan

2.6k total citations
40 papers, 2.1k citations indexed

About

L. Morgan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, L. Morgan has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Oncology. Recurrent topics in L. Morgan's work include Diabetes Treatment and Management (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). L. Morgan is often cited by papers focused on Diabetes Treatment and Management (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). L. Morgan collaborates with scholars based in United Kingdom, Singapore and Ireland. L. Morgan's co-authors include Stephen Hiscox, Robert I. Nicholson, Denise Barrow, V. Marks, Cátia Martins, Helen Truby, S. Hampton, B. A. J. Evans, Osamu Arisaka and Noriko Miyake and has published in prestigious journals such as Gastroenterology, Scientific Reports and Journal of Nutrition.

In The Last Decade

L. Morgan

39 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Morgan United Kingdom 23 704 563 399 369 318 40 2.1k
Jackie A. Lavigne United States 23 706 1.0× 465 0.8× 252 0.6× 508 1.4× 112 0.4× 28 1.9k
Jennifer B. Collins United States 28 1.4k 1.9× 299 0.5× 337 0.8× 265 0.7× 113 0.4× 39 2.7k
Rodrigo P. A. Barros United States 15 484 0.7× 205 0.4× 441 1.1× 349 0.9× 107 0.3× 17 1.7k
Enikö Kállay Austria 35 1.1k 1.5× 507 0.9× 422 1.1× 454 1.2× 295 0.9× 83 3.4k
Hassane Amlal United States 32 1.8k 2.5× 180 0.3× 411 1.0× 410 1.1× 170 0.5× 65 2.7k
Marie K. Lindberg Sweden 12 670 1.0× 342 0.6× 684 1.7× 192 0.5× 114 0.4× 16 1.9k
Robert E. McGehee United States 27 1.6k 2.3× 239 0.4× 364 0.9× 1.5k 4.1× 183 0.6× 48 3.6k
Aymen I. Idris United Kingdom 23 836 1.2× 489 0.9× 137 0.3× 286 0.8× 80 0.3× 62 2.0k
Gregory Collier Australia 18 595 0.8× 108 0.2× 197 0.5× 767 2.1× 533 1.7× 24 2.0k

Countries citing papers authored by L. Morgan

Since Specialization
Citations

This map shows the geographic impact of L. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Morgan more than expected).

Fields of papers citing papers by L. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Morgan. The network helps show where L. Morgan may publish in the future.

Co-authorship network of co-authors of L. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of L. Morgan. A scholar is included among the top collaborators of L. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Morgan. L. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, L., et al.. (2018). Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis. International Journal of Cancer. 143(10). 2537–2550. 15 indexed citations
2.
Pepper, Chris, Jassem G. Mahdi, Andrea G.S. Buggins, et al.. (2011). Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation. 44(4). 380–390. 24 indexed citations
3.
Evans, B. A. J., Matthew Bull, Richard Fox, et al.. (2010). The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats. Journal of Endocrinology. 208(1). 69–79. 9 indexed citations
4.
Morgan, L., Robert I. Nicholson, & Stephen Hiscox. (2008). Src as a Therapeutic Target in Breast Cancer. Endocrine Metabolic & Immune Disorders - Drug Targets. 8(4). 273–278. 16 indexed citations
5.
Hiscox, Stephen, Nicola Jordan, Christopher G. Smith, et al.. (2008). Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Research and Treatment. 115(1). 57–67. 59 indexed citations
6.
Martins, Cátia, L. Morgan, & Helen Truby. (2008). A review of the effects of exercise on appetite regulation: an obesity perspective. International Journal of Obesity. 32(9). 1337–1347. 184 indexed citations
7.
Hiscox, Stephen, L. Morgan, Tim Green, & Robert I. Nicholson. (2006). Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocrine Related Cancer. 13(Supplement_1). S53–S59. 40 indexed citations
8.
Hiscox, Stephen, L. Morgan, Tim P. Green, et al.. (2005). Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Research and Treatment. 97(3). 263–274. 201 indexed citations
9.
Hiscox, Stephen, Wen G. Jiang, KM Taylor, et al.. (2005). Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation. International Journal of Cancer. 118(2). 290–301. 222 indexed citations
10.
Hiscox, Stephen, et al.. (2004). 406 Reduction of in vitro metastatic potential of tamoxifen-resistant breast cancer cells following inhibition of Src kinase activity by AZD0530. European Journal of Cancer Supplements. 2(8). 121–122. 1 indexed citations
11.
Hiscox, Stephen, L. Morgan, Denise Barrow, et al.. (2004). Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839). Clinical & Experimental Metastasis. 21(3). 201–212. 93 indexed citations
12.
Sutton, J. A., et al.. (2002). Physiological interpretation of electrical impedance epigastrography measurements. Physiological Measurement. 24(1). 45–55. 14 indexed citations
13.
Morton, Michael S., Osamu Arisaka, Noriko Miyake, L. Morgan, & B. A. J. Evans. (2002). Phytoestrogen Concentrations in Serum from Japanese Men and Women over Forty Years of Age. Journal of Nutrition. 132(10). 3168–3171. 234 indexed citations
14.
Hampton, S., et al.. (2001). Postprandial Triacylglycerol Responses in Simulated Night and Day Shift: Gender Differences. Journal of Biological Rhythms. 16(3). 272–276. 27 indexed citations
15.
Hampton, S., et al.. (2001). Postprandial Triacylglycerol Responses in Simulated Night and Day Shift: Gender Differences. Journal of Biological Rhythms. 16(3). 272–276. 23 indexed citations
16.
Ranganath, L., et al.. (1998). The ageing entero-insular axis. Diabetologia. 41(11). 1309–1313. 44 indexed citations
17.
Morgan, L., Joséphine Arendt, Deborah S. Owens, et al.. (1998). Effects of the endogenous clock and sleep time on melatonin, insulin, glucose and lipid metabolism. Journal of Endocrinology. 157(3). 443–451. 98 indexed citations
18.
Hampton, S., et al.. (1998). Altered postprandial hormone and metabolic responses in a simulated shift work environment. Journal of Endocrinology. 158(3). 305–310. 124 indexed citations
19.
Ranganath, L., F Norris, L. Morgan, Jeremy Wright, & V. Marks. (1998). Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Diabetic Medicine. 15(2). 120–124. 61 indexed citations
20.
Morgan, L., J. Michael Tredger, Jane Wilkinson, et al.. (1992). Post-prandial GIP responses to a mixed meal in lean and obese subjects. Regulatory Peptides. 40(2). 213–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jackie A. Lavigne Breakdown of academic impact, for papers by Jennifer B. Collins Breakdown of academic impact, for papers by Rodrigo P. A. Barros Breakdown of academic impact, for papers by Enikö Kállay Breakdown of academic impact, for papers by Hassane Amlal Breakdown of academic impact, for papers by Marie K. Lindberg Breakdown of academic impact, for papers by Robert E. McGehee Breakdown of academic impact, for papers by Aymen I. Idris Breakdown of academic impact, for papers by Gregory Collier
Rankless by CCL
2026